rediff.com
India As It Happens
India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
rediff News App
Hi Guest
About 1232 results for "ranbaxy"
 |
Ranbaxy Laboratories Limited (RANBAXY) - Pharmaceuticals & Hea...Ranbaxy Laboratories Limited (Ranbaxy) is an integrated research-based international pharmaceutical company, offering a wide range of generic medicines. The company operates through two business segments, namely, Pharmaceuticals and Other ... TransWorldNews, 1 day ago |
See all (322) images for "ranbaxy" | ||||
See all (322) images for "ranbaxy"
Firstpost.com
|
Why whistle blowing is so hard in IndiaRecent news on Ranbaxy has prominently featured the role of Dinesh Thakur, a whistleblower. Thakur, who worked at Ranbaxy for four months was responsible for blowing the lid on the company s falsification of certification documents submitted to drug ... Forbes India, 1 day ago
Sound legal basis key to facilitate whistle blowing
Firstpost.com, 1 day ago
Ranbaxy issue, a wake-up call for India
Business Line, 4 days ago
|
Statement By Dinesh Thakur Regarding US Government's Case Against Ranbaxy/PRNewswire-USNewswire/ -- Today, the United States government brought to a conclusion an eight-year criminal and civil investigation of Ranbaxy Laboratories Limited, India's largest generic drug company, and Ranbaxy, Inc., Ranbaxy Pharmaceuticals, ... AndhraNews.net, 1 day ago
|
India's Largest Generic Drugmaker Ranbaxy Pays $500 Million to Settle Systemic Generic Drug Manufacturing FraudStein Mitchell Muse & Cipollone LLP Announces Largest Generic Drug Whistleblower Settlement in History WASHINGTON, May 13, 2013 /PRNewswire-USNewswire/ -- Stein Mitchell Muse & Cipollone LLP announced today that Ranbaxy Laboratories Limited ... AndhraNews.net, 1 day ago
Indias Largest Generic Drugmaker Ranbaxy Pays $500 Mi. . .
Equities.com, 5 days ago
|
Money Control
|
Buy Ranbaxy with a target price of Rs 492: Ashwani GujralAshwaniGujral, Fund Manager, Ashwanigujral.com, shares his views on Ranbaxy. ET Now: What is your view on Ranbaxy? Ashwani Gujral: Ranbaxy is a 'BUY' call with a target of Rs 492 and a stop loss of Economic Times, 2 days ago
Hold Ranbaxy in portfolio, says Atul Badkar
Money Control, 3 days ago
Check Out: Super Six stocks for May 15
Money Control, 3 days ago
Buy Ranbaxy with a target of Rs 462: Ashwani Gujral
Economic Times, 4 days ago
More from: , Smart Investor...and 2 other sources
|
Money Today
|
...shares end nearly 4% higher.Shares of Ranbaxy Laboratories recovered from early losses and settled nearly 4 per cent higher on hopes that settlement of its long lawsuit in the US would be positive for drug maker the in the long term. The stock opened weak on the BSE and fell ... New Delhi Pioneer, 4 days ago
Ranbaxy shrugs off US lawsuit settlement; ends up 4%
Money Control, 4 days ago
Ranbaxy recovers ground; shares end 4% higher
Economic Times, 4 days ago
Ranbaxy recovers lost ground
Times of India, 4 days ago
More from: , Money Today...and 2 other sources
|
First Post.com
|
This man made $49 mn by blowing the whistle on RanbaxyAn ex-Ranbaxy Director and Global Head, Research Information & Portfolio Management, Thakur played a key role in providing evidence to the US FDA about the company falsifying data and violating ethical management practices. First Post.com, 3 days ago
Ranbaxy whistleblower to get Rs 266 crore
NDTV Profit, 4 days ago
Ranbaxy whistleblower Thakur richer by Rs 266cr; speaks out
Money Control, 4 days ago
Ranbaxy whistleblower Dinesh Thakur to get Rs. 266 crore
NDTV Profit, 4 days ago
More from: , NDTV Profit...and 2 other sources
|
RTTNews.com
|
Ranbaxy Laboratories Q1 profit plunges to Rs. 125.75 croreRanbaxy Laboratories Ltd has announced the financial results for the quarter ended March 31, 2013.The Company has posted a net profit of Rs. 701.47 million for the quarter ended March 31, 2013 as compared to Rs. 8272.31 million for the quarter ended ... Equity Bulls, 6 days ago
Ranbaxy shares down 2% as Q1 earnings short of estimates
Money Control, 1 week ago
Ranbaxy profit dips
The Telegraph, 1 week ago
Ranbaxy Laboratories consolidated net profit plunges
The Hindu, 1 week ago
|
India needs a strong whistleblowers lawThe role of a whistleblower in exposing the Ranbaxy fraud in the US has once again underlined the need for a strong whistleblower's law in India. Dinesh Thakur, the whistleblower of Indian origin, would not have succeeded in India as people like him ... New Indian Express, 3 days ago
Whistle-blowers back in spotlight
Smart Investor, 3 days ago
Why Whistle?
Financial Express, 2 days ago
|
Ranbaxy may take a $1-billion hit in USThe damage to Indias largest drug major, Ranbaxy , translates well beyond the $500 million -which was confirmed as total penalty on May 13. Economic Times, 4 days ago
Ranbaxy may take a $1bn hit
Times of India, 4 days ago
|
Prev
| Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
►AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts
rediff News App
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Widget
Get Realtime News on your webpage & get your members hooked!
Happening by Location
Click on any location on map to view latest news by location
